Scholar
IQ
Help
Try ScholarIQ free
Home
Papers
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
Upload Records
Snowball Search
Search OpenAlex
About the database
ScholarIQ
answers from OpenAlex
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
Paper
Citations, authors & open-access status
2,214
Citations
2,017
Year
bronze
OA Status
IDs:
DOI
PMID
OpenAlex
Related on ScholarIQ
Jeffrey S. Weber
Author
Piotr Rutkowski
Author
Michael Smylie
Author
René González
Author
Georgina V. Long
Author
Michael B. Atkins
Author
470M+ articles · free account